Additionally, the characterization of genetic and other regulatory mechanisms that may affect LIGHT signaling networks have revealed new strategies to treat a wide range of diseases, including autoimmune disorders, inflammatory diseases, and cancer. This evidence concerns the gene TNFSF14 and autoimmune disease.